Prostate Cancer Theranostics - An Overview

Area of Science:

• Oncology
• Nuclear Medicine
• Molecular Imaging

Background:

• Metastatic prostate cancer remains incurable, necessitating advancements in early detection and targeted treatment.
• Molecularly specific tools are crucial for localizing diagnostic and therapeutic radionuclide payloads to prostate cancer cells and the tumor microenvironment.
• Theranostic approaches are emerging as a key strategy for characterizing and personalizing patient management in prostate cancer.

Purpose of the Study:

• To review clinically translated theranostic approaches for prostate cancer.
• To summarize methods for detecting, characterizing, and treating prostate cancer using molecularly specific tools.
• To highlight the expanding field of theranostics in managing prostate cancer.

Main Methods:

• Literature review of clinically translated theranostic strategies.
• Analysis of molecularly specific tools for radionuclide payload delivery.
• Summary of approaches for prostate cancer detection, characterization, and treatment.

Main Results:

• Theranostic approaches are increasingly being realized for prostate cancer patients.
• Molecularly specific tools enable precise localization of diagnostic and cytotoxic agents.
• The field of theranostics for prostate cancer is rapidly expanding with clinically relevant applications.

Conclusions:

• Clinically translated theranostic approaches are vital for advancing prostate cancer management.
• Molecularly targeted radionuclide therapies offer a promising avenue for treating metastatic disease.
• Personalized patient management through theranostics is transforming prostate cancer care.